Navigation Links
Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
Date:4/21/2009

herapeutics. Factors that may cause such differences include risks related to our limited operating history, risks associated with completing our clinical trials, the risk that the safety and/or efficacy results of existing clinical trials or from additional clinical trials will not support approval for a marketing license, the risk that the FDA may interpret data differently than we do or require more data or a more rigorous analysis of data than expected, the risk that the FDA will not approve a product for which a marketing license has been applied, the risk that the results of a clinical trial may not be indicative of results obtained in a later clinical trial, risks that we may lack the financial resources and access to capital to fund required clinical trials, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks that could affect Dendreon's business, financial condition and results of operations are contained in Dendreon's public disclosure filings with the U.S. Securities and Exchange Commission, which are available at www.sec.gov.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
8. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
11. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... LONDON , May 6, 2015 ... HIV maintenance therapy with dolutegravir and rilpivirine ... start of a Phase III clinical trial programme ... (Tivicay®) and rilpivirine (Edurant® [1] ) as maintenance ... III programme comprises two replicate studies evaluating 48 ...
(Date:5/6/2015)... , May 6, 2015   Wilson Therapeutics ... CEO Jonas Hansson has been invited to ... the annual BioEquity Conference, this year to be held ... May 19 th . About WTX101 ... is currently in Phase 2 testing for Wilson Disease. ...
(Date:5/6/2015)... , May 6, 2015 ... join the Wellcome Trust and the Bill & ... Kymab, a leading monoclonal antibody biopharmaceutical ... an additional US$50 million to complete a US$90 ... being invested by Woodford Patient Capital Trust plc ...
Breaking Medicine Technology:ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 2ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 3ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 4ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 5ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 6ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 7ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 8ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 9ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy 10Wilson Therapeutics To Present As A "Next Wave" Company During BioEquity 2015 Conference In Vienna On May 19th 2Kymab Secures US$90 Million Funding 2Kymab Secures US$90 Million Funding 3Kymab Secures US$90 Million Funding 4
... 2011  Allocate Software plc, the leading provider of workforce ... its presence in the US with the announcement that ... scheduling solution, to create and manage schedules for its ... a leading provider of a diverse range of imaging ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that ... present a corporate overview at the Bank of America Merrill ... at 7:30 a.m. ET.  The conference will be held at ... A live webcast and audio archive of the presentation will ...
Cached Medicine Technology:Allocate Software's Healthroster Selected by Austin Radiological Association 2
(Date:5/6/2015)... 06, 2015 Chinese technology company, Elink-IOT, ... Kickstarter to raise AUD$150,000 to finalize development of Watcher, ... a smart watch designed to help the owner keep ... wearer when the item is out of range. ... inform the wearer and sends alerts on its E-paper ...
(Date:5/6/2015)... 2015 LINET Americas has been awarded ... the small business category. The award was given for ... Award is given on an annual basis to foreign ... contributions to philanthropy. Since 1998, the Charlotte International ... the Mayor’s International Community Awards. The award was presented ...
(Date:5/6/2015)... The beverage industry has grocery and natural food ... and superfruit fusions stands out among all of them. ... these delicious juice blends are making a splash in ... hydrate. , In collaboration with National Beverage Day on ... bottle of Lemongrass Tea and Ginseng, Black Tea and ...
(Date:5/5/2015)... The Florida Comprehensive Epilepsy and Seizure Disorders Center ... the National Association of Epilepsy Centers (NAEC) as ... a specialized epilepsy center is to provide an ... seizure syndrome, comprehensive epilepsy education for patients and ... diagnosis and surgical treatment or access to it ...
(Date:5/5/2015)... 2015 NCPDP announced today that ... program establishes a three-year commitment of strategic support for ... Elite Partners. “AmerisourceBergen has supported our multi-stakeholder forum over ... “and this is a wonderful continuation and expansion of ... trace AmerisourceBergen back to our very first Board of ...
Breaking Medicine News(10 mins):Health News:Crowdfunding campaign Launched for World’s First Anti-Loss Smart Watch 2Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:Florida Hospital Tampa Epilepsy Program Earns Designation as a Level 4 Epilepsy Center by the National Association of Epilepsy Centers (NAEC) 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3
... , LANSING, Ill., Dec. 23 It,s not too ... of Davidson,s Safest Choice Pasteurized Shell Eggs, best holiday recipe ... celebrate the season and remind at-home chefs and bakers about ... runs through Dec. 31, 2009. , Recipe submissions ...
... ... a new leader who will help expand its offerings of novel, engaging scientifically based ... ... healthcare reform, one fact remains: the heavy lifting to move an unhealthy population toward ...
... Seek to retain federal policy on abortion funding and ... health care that immigrants have now, remove barriers to access ... coverage standards , WASHINGTON, Dec. 22 The current ... forward without "essential changes," the chairmen of three committees of ...
... , , WASHINGTON, Dec. 22 ... in the 8th Circuit Court of Appeals, detailing the links between ... brief seeks to overturn a lower court,s decision that abortion providers ... risks. , "Abortion is not a safe choice for women," noted ...
... , WASHINGTON, Dec. 22 St. John ... pay the United States $13,229,348.88 to settle allegations that ... announced today. , The United Sates alleges that ... were tainted by the hospital,s financial relationships with referring ...
... ... system and self-generated alerts are the backbone of our EHR,” says Kepila. “If abnormal ... posted by The CareData Solution to the patient and the provider,s PHR, personal health ... (PRWEB) ...
Cached Medicine News:Health News:Food Safety Leader National Pasteurized Eggs Searches for Best Holiday Recipes 2Health News:New Executive Director to Lead Medical Education to Greater Relevance 2Health News:Bishops Call Senate Health Care Reform Bill 'Deficient,' Essential Changes Needed Before Moving Forward 2Health News:Bishops Call Senate Health Care Reform Bill 'Deficient,' Essential Changes Needed Before Moving Forward 3Health News:Americans United for Life Files Brief Detailing Abortion's Suicide Risk 2Health News:Oklahoma Hospital Group Pays U.S. $13 Million to Settle False Claims Act Allegations 2Health News:CareData Solutions EHR v2.7, Receives Full CCHIT Certification 2
... The AlphaPette Pipettor is the ... beyond. Offers accuracy, comfort, and reliability. ... digital volume readout sub-micrometer. Easy interchangeable ... or tiny hands. Adjustable rapid pipet ...
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
... Thermo Labsystems was designed specifically to combine ... such as the new fast dial system ... help to define this as a new ... interchangeable handle plate offers a custom fit ...
... In the specialty areas ... or intensive care work, it ... in your practice. Alokas motorized ... Doppler and Tissue Harmonic Echo ...
Medicine Products: